PubMed HealthSearch

Biomedical subjects

L A Morris

Publications and source records attributed to L A Morris.

9 recordsLinked to original sources

Effects of written drug information on patient knowledge and compliance: a literature review.

The prospect of patient-oriented prescription drug labeling has focused increased attention on the effectiveness of written information for the consumer. Studies which have evaluated the effects of written prescription drug information in a patient population are reviewed. Several studies indicate that written information can be effective in improving patient compliance with regimens for antibiotic therapy. However, for drugs used on a long-term basis, written information as a sole intervention has not been shown to be sufficient for improving patient compliance. Patient knowledge of less commonly known information, such as precautions, side effects, or special directions is frequently improved by written information. Listing a drug's side effects has not been shown to increase the reported experience of side effects; however, one study suggests that patients may be more willing to report side effects to a health professional if they are listed in the written information. The trend for recent studies has been to focus on the "milieu" in which written information is provided or to systematically vary structural features of the information in order to improve the quality of drug communications.

Administration, Oral

Patient attitudes about two forms of printed oral contraceptive information.

The desired form and style of written drug information for patients were assessed in a national survey of oral contraceptive (OC) users. These women were queried about two forms of OC information: a short insert included with dispensed drugs and a longer brochure delivered by the physician upon patient request. Longer and more detailed information, especially concerning drug dangers and directions for use, was strongly preferred. Younger and more educated women were more likely to report receiving the OC brochure and to desire more comprehensive information. Most respondents found information in both the insert and the brochure clear and useful, and felt it was important to include written information with other prescription drugs. The longer brochure was preferred over the shorter insert as a model of drug information to be included with additional drugs.

Adolescent

Rationale for patient package inserts.

The need for patient package inserts (PPIs) is discussed in terms of the "consumers' right-to-know" and "patient health education" themes, as well as the premise that verbal means of communication are often inadequate. Some of the reasons for the frequent failure of verbal messages are reviewed by detailing the five stages through which any communication must be processed in order to be effective. Verbal information may be inadequate because: (1) patients are not exposed to necessary material, (2) they may not pay attention to the information, (3) they may not understand it, (4) the information may not be accepted as valid, and (5) patients may not remember the material. Written communication which must be processed through the same five stages also may be frequently inadequate. Therefore, PPIs must be viewed as reinforcing and augmenting verbal consultation, and both written and verbal forms are necessary. Consumer surveys and demonstration projects have shown that written communications are a desired and effective means for conveying additional prescription drug information to patients. The wide implementation of PPIs is apt to cause many problems for the pharmacists; however, it may also serve as a means to enhance the pharmacist's clinical role.

Drug Packaging

A survey of the effects of oral contraceptive patient information.

A nationwide survey of 1,720 current and 949 former oral contraceptive (OC) users gathered information about receipt, readership, knowledge, opinions, and reported behavioral changes induced by two forms of patient-oriented OC information. A substantial majority of women said they received and read the patient insert dispensed with the drug. However, only about one third of pill users said that they received the longer informational brochure supplied by physicians on patient request. Directions for use and side effects were the most often recalled information. Physician-patient contact patterns were reported as generally unaffected by written patient information. Respondents preferred the longer informational brochure to the insert. Survey results have implications for recently proposed changes in required OC patient information and for the development of patient information on additional prescription drugs.

Adolescent